Company · CIK 0001788028 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Jasper Therapeutics, Inc. · JSPR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 AForm 4 → | Aug 4, 4:11 pm EDT | Thomas G WiggansDirector | 7,500 | — | — | 7,500 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:10 pm EDT | Svetlana LucasDirector | 7,500 | — | — | 7,500 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:10 pm EDT | Patrick J CrutcherDirector | 7,500 | — | — | 7,500 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:10 pm EDT | Kurt Von EmsterDirector | 7,500 | — | — | 7,500 | — | |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:10 pm EDT | Judith Anne ShizuruDirector | 7,500 | — | — | 7,500 | — | |
| Jul 20, 2026 PForm 4 → | Jul 22, 7:10 pm EDT | Matthew E RosChief Operating Officer | 881 | — | — | 881 | — | |
| Jul 16, 2026 APForm 4 → | Jul 20, 8:38 pm EDT | Patrick J CrutcherDirector | 15,888 | — | — | 888 | — |